ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.
Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
- Receipt of royalties
- Speakers' bureau
- Other
The faculty reported the following disclosures.
Question Authors
- Justus Fiechtner, MD - No relevant financial relationships to disclose
- Prateek Gandiga, MD - No relevant financial relationships to disclose
- Jennifer Medlin, MD - No relevant financial relationships to disclose
- Abhishek Nandan, MD - No relevant financial relationships to disclose
- Jennifer Stichman, MD - No relevant financial relationships to disclose
- Huzaefah Syed, MD - No relevant financial relationships to disclose
Question Reviewers
- Meghan Clowse, MD - Exagen Diagnostics2, GlaskSmithKline5, Corbus5, EMD-Serono5, Galapagos5, 9, Pfizer2, UCB5
- Jeffrey Gelfand, MD - Amgen2 (spouse), Roche/Genentech2, Biogen5 (spouse), Alexion5 (spouse), Theranica5, Impel Neuropharma5, Advanced Clinic5, Biohaven5Satsuma5, UpToDate7 (spouse)
- James Rosenbaum, MD - AbbVie5 , Corvus5 , Eyevensys5, Gilead5, Horizon2, Novartis5, Pfizer2,Santen5, Roche5, UpToDate7
- E. William St.Clair, MD - Bristol Myers Squib2, 5
- John Stone, MD - Roche/Genentech2, 5